Back to User profile » Prof. Dr. Shih-Lung Cheng
Papers published by Prof. Dr. Shih-Lung Cheng:
The impact of 2011 and 2017 Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD) guidelines on allocation and pharmacological management of patients with COPD in Taiwan: Taiwan Obstructive Lung Disease (TOLD) study
Hsieh MJ, Huang SY, Yang TM, Tao CW, Cheng SL, Lee CH, Kuo PH, Wu YK, Chen NH, Hsu WH, Hsu JY, Lin MS, Wang CC, Wei YF, Tsai YH
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:2949-2959
Published Date: 25 September 2018
Increased risk of community-acquired pneumonia in COPD patients with comorbid cardiovascular disease
Lin SH, Perng DW, Chen CP, Chai WH, Yeh CS, Kor CT, Cheng SL, Chen JJ, Lin CH
International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:3051-3058
Published Date: 5 December 2016
Effectiveness using higher inhaled corticosteroid dosage in patients with COPD by different blood eosinophilic counts
Cheng SL, Lin CH
International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:2341-2348
Published Date: 21 September 2016
A review of omalizumab for the management of severe asthma
Lin CH, Cheng SL
Drug Design, Development and Therapy 2016, 10:2369-2378
Published Date: 26 July 2016
Predictive factors warrant screening for obstructive sleep apnea in COPD: a Taiwan National Survey
Hang LW, Hsu JY, Chang CJ, Wang HC, Cheng SL, Lin CH, Chan MC, Wang CC, Perng DW, Yu CJ
International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:665-673
Published Date: 30 March 2016
COPD in Taiwan: a National Epidemiology Survey
Cheng SL, Chan MC, Wang CC, Lin CH, Wang HC, Hsu JY, Hang LW, Chang CJ, Perng DW, Yu CJ
International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:2459-2467
Published Date: 11 November 2015
Wheezing, a significant clinical phenotype of COPD: experience from the Taiwan Obstructive Lung Disease Study
Huang WC, Tsai YH, Wei YF, Kuo PH, Tao CW, Cheng SL, Lee CH, Wu YK, Chen NH, Hsu WH, Hsu JY, Wang CC, Lin MS
International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:2121-2126
Published Date: 7 October 2015
Factors associated with the prescription of inhaled corticosteroids in GOLD group A and B patients with COPD – subgroup analysis of the Taiwan obstructive lung disease cohort
Wei YF, Kuo PH, Tsai YH, Tao CW, Cheng SL, Lee CH, Wu YK, Chen NH, Hsu WH, Hsu JY, Lin MS, Wang CC
International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:1951-1956
Published Date: 14 September 2015
Chronic obstructive pulmonary disease treated with inhaled medium- or high-dose corticosteroids: a prospective and randomized study focusing on clinical efficacy and the risk of pneumonia
Cheng SL, Su KC, Wang HC, Perng DW, Yang PC
Drug Design, Development and Therapy 2014, 8:601-607
Published Date: 28 May 2014
Early achievement and maintenance of stable asthma control using initially higher-dose inhaled corticosteroids as part of combination therapy: an open-label pilot study
Cheng SL, Wang HC, Kuo SH
Drug Design, Development and Therapy 2013, 7:477-484
Published Date: 17 June 2013